Health Lauran Neergaard — Associated Press Huge U.S. study starts sharing gene findings with volunteers
Biotech Megan Molteni STAT Plus: ‘Make People Better’: The CRISPR babies story you probably don’t know, and how it was filmed in real-time
Health Andrew Joseph STAT Plus: England to sequence genomes of 100,000 newborns, to try to catch illness earlier
Health Isabella Cueto Revenge of the gaslit patients: Now, as scientists, they’re tackling Ehlers-Danlos syndromes
In the Lab Megan Molteni On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues
In the Lab Megan Molteni After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback
In the Lab Megan Molteni Provocative new findings suggest a surprising cause of Down syndrome: cells linked to aging
Biotech Laura Ungar — Associated Press STAT Plus: Promising gene therapy delivers treatment directly to brain
Biotech Jonathan Wosen STAT Plus: Invitae’s new CEO on why the genetic testing firm stopped chasing ‘volume at all costs’
Biotech Jonathan Wosen STAT Plus: Upstart Element ratchets up race for cheaper DNA sequencing with a $200 genome
In the Lab Jonathan Wosen Study offers a genetic explanation for why some drugs trigger a deadly brain disease
Biotech Ryan Cross — The Boston Globe STAT Plus: mRNA startup Strand Therapeutics raises millions to test targeted cancer therapies
Biotech Megan Molteni STAT Plus: Perfection is too high a bar for CRISPR treatments, says STAT Biomedical Innovation Award winner David Liu
Biotech Usha Lee McFarling STAT Plus: ‘Science is just rocketing forward’: A Q&A with former NIH director Francis Collins
Biotech Jonathan Wosen STAT Plus: Pacific Biosciences, known for niche DNA sequencing, looks to rival Illumina with new product launch
Health Brittany Trang Black Death may have influenced evolution of genes involved in immune responses, study finds
In the Lab Megan Molteni Human neurons implanted in a rodent’s brain lead a rat to water — and make it drink
First Opinion Gigi Kwik Gronvall STAT Plus: Needed: stricter screening of gene synthesis orders, customers
In the Lab Megan Molteni Who will get the call from Stockholm? It’s time for STAT’s 2022 Nobel Prize predictions
Biotech Jonathan Wosen STAT Plus: With rivals on its heels, Illumina launches a new line of high-end DNA sequencers
Biotech Jason Mast STAT Plus: Biotech turns to new and strange viruses to overcome gene therapy’s limitations
Biotech Allison DeAngelis STAT Plus: New CRISPR startup, drawing big-name backers, seeks to fix diseases caused by large DNA errors
First Opinion Sonia M. Suter and Laura Hercher Dobbs decision is a huge setback for genetic counseling and the people who need it
Health Emiliano Rodríguez Mega A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end ‘parachute science,’ too?
A STAT Investigation Allison DeAngelis, Adam Feuerstein and Jason Mast STAT Plus: At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say
In the Lab Elizabeth Cooney New research digs into the genetic drivers of heart failure, with an eye to precision treatments
First Opinion David Reese and Kári Stefánsson A better understanding of human diversity is needed to equitably advance precision medicine
Biotech Matthew Herper and Megan Molteni STAT Plus: Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease